Dr Peter Pockney
Senior Lecturer
School of Medicine and Public Health (Medicine)
- Email:peter.pockney@newcastle.edu.au
- Phone:(02) 4985 5527
Career Summary
Biography
Dr Peter Pockney has been the Senior Lecturer in Surgery at the University of Newcastle since 2011. In this role, he combines an active teaching and research commitment to the School of Medicine and Public Health with clinical practice as a specialist colorectal, general and trauma surgeon at the John Hunter Hospital, Newcastle.
Peter completed undergraduate medicine at University College London in 1996, graduating with Distinction in Surgery and Merit in Medicine. He did basic clinical training at University College London, Southampton University Hospitals and Cambridge University Hospitals before completing his Doctorate of Medicine in 2004 at Southampton University under the Supervision of Professor John Primrose. This research was in the field of surgical randomised clinical trials, which remained the main focus of his research activity until 2016.
After finishing research training and his DM, Peter completed higher surgical training in 2007, specialising in General and Colorectal surgery. A subspecialty fellowship in Newcastle, NSW in 2008 was followed by 2 years working as a Consultant Surgeon in London.
Peter returned to Newcastle as the Senior Lecturer in Surgery in 2011. He has the role of course coordinator for surgery in the BMed, which includes responsibility for course and assessment design, and approximately 10 hours a week contact time teaching with the students.
His research activity has included being the Chief Investigator and contributor to 5 randomised clinical trials aimed at improving outcomes after major colorectal surgery, and three prospective studies of biomarkers as indicators of adverse events in surgery. He has also led a major project in service redesign to improve access to colonoscopy for people at high risk of bowel cancer, and a further study that improved cost effectiveness and efficiency in the operating theatre during common surgical procedures.
In 2016 he led an initiative that brought together the Hunter New England Local Health District and the University of Newcastle to support 4 Junior Clinical Fellows in Surgical Research and Teaching. These Fellows are funded through part-time work for the hospital to teach undergraduate students and to conduct high quality research. The projects being undertaken include examining the role of circulating cell free tumour DNA as a biomarker for colorectal cancer, the role of Neutrophil Extracellular Traps in colorectal cancer metastases, neurotrophic growth factors in prostate cancer, a randomised clinical trial of prehabilitation in major upper gastrointestinal surgery, and a multicentre audit of emergency laparotomy operations.
This program is being extended in 2018, with 12 positions being offered across General and Colorectal Surgery, Neurosurgery, Cardiothoracic surgery and Trauma surgery. Other projects being undertaken under his supervision include examining the role of the colonic microbiome in anastomotic leaks, the utility of a biomarker in diagnosis of acute appendicitis, and the role of variations in the genome of CD36 in the phenotype of Familial Adenomatous Polyposis.
Membership
Royal Australasian College of Surgeons, Section of Academic Surgeons
Colorectal Surgical Society of Australia and New Zealand
Qualifications
- Doctor of Medicine, University of Southampton - UK
- Bachelor of Science (Honours)(Geography), University of Exeter - UK
- Bachelor of Medicine, Bachelor of Surgery, University of London
- Post Graduate Cert-Completion of Train(Gen Surgery, Post Graduate Medical Educ & Training Board - UK
Keywords
- Clinical Trials
- Colorectal Cancer
- Colorectal Cancer Screening
- Colorectal Surgery
- FAP
- Neutrophil Extracellular Traps
Fields of Research
| Code | Description | Percentage |
|---|---|---|
| 080799 | Library and Information Studies not elsewhere classified | 30 |
| 110399 | Clinical Sciences not elsewhere classified | 35 |
| 111799 | Public Health and Health Services not elsewhere classified | 35 |
Professional Experience
UON Appointment
| Title | Organisation / Department |
|---|---|
| Senior Lecturer | University of Newcastle School of Medicine and Public Health Australia |
Professional appointment
| Dates | Title | Organisation / Department |
|---|---|---|
| 11/01/2011 - 21/07/2028 |
Consultant Surgeon Consultant Colorectal and General Surgeon. |
John Hunter Hospital, Newcastle Colorectal Surgery Australia |
Publications
For publications that are currently unpublished or in-press, details are shown in italics.
Journal article (23 outputs)
| Year | Citation | Altmetrics | Link | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
Smith SR, Murray D, Pockney PG, Bendinelli C, Draganic BD, Carroll R, 'Tranexamic Acid for Lower GI Hemorrhage: A Randomized Placebo-Controlled Clinical Trial', Diseases of the Colon and Rectum, 61 99-106 (2018) [C1] © 2017 The American Society of Colon and Rectal Surgeons, Inc. BACKGROUND: Lower GI hemorrhage is a common source of morbidity and mortality. Tranexamic acid is an antifibrinolyti... [more] © 2017 The American Society of Colon and Rectal Surgeons, Inc. BACKGROUND: Lower GI hemorrhage is a common source of morbidity and mortality. Tranexamic acid is an antifibrinolytic that has been shown to reduce blood loss in a variety of clinical conditions. Information regarding the use of tranexamic acid in treating lower GI hemorrhage is lacking. OBJECTIVE: The aim of this trial was to determine the clinical efficacy of tranexamic acid when used for lower GI hemorrhage. DESIGN: This was a prospective, double-blind, placebo-controlled, randomized clinical trial. SETTINGS: The study was conducted at a tertiary referral university hospital in Australia. PATIENTS: Consecutive patients aged > 18 years with lower GI hemorrhage requiring hospital admission from November 2011 to January 2014 were screened for trial eligibility (N = 265). INTERVENTIONS: A total of 100 patients were recruited after exclusions and were randomly assigned 1:1 to either tranexamic acid or placebo. MAIN OUTCOME MEASURES: The primary outcome was blood loss as determined by reduction in hemoglobin levels. The secondary outcomes were transfusion rates, transfusion volume, intervention rates for bleeding, length of hospital stay, readmission, and complication rates. RESULTS: There was no difference between groups with respect to hemoglobin drop (11 g/L of tranexamic acid vs 13 g/L of placebo; p = 0.9445). There was no difference with respect to transfusion rates (14/49 tranexamic acid vs 16/47 placebo; p = 0.661), mean transfusion volume (1.27 vs 1.93 units; p = 0.355), intervention rates (7/49 vs 13/47; p = 0.134), length of hospital stay (4.67 vs 4.74 d; p = 0.934), readmission, or complication rates. No complications occurred as a direct result of tranexamic acid use. LIMITATIONS: A larger multicenter trial may be required to determine whether there are more subtle advantages with tranexamic acid use in some of the secondary outcomes. CONCLUSIONS: Tranexamic acid does not appear to decrease blood loss or improve clinical outcomes in patients presenting with lower GI hemorrhage in the context of this trial. see Video Abstract at http://links.lww.com/DCR/A453.
|
||||||||||
| 2018 |
Almazi JG, Pockney P, Gedye C, Smith ND, Hondermarck H, Verrills NM, Dun MD, 'Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.', Proteomics. Clinical applications, e1700121 (2018)
|
||||||||||
| 2017 |
Zala A, Bollipo SJ, Pockney P, Foster R, '1038 Endoscopic Removal of a Large Kitchen Knife', Gastrointestinal Endoscopy, 85 AB126-AB126 (2017)
|
||||||||||
| 2017 |
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al., 'Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases', Annals of Surgery, 266 111-117 (2017) [C1] Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study aims to report short-term clinical and oncological outcomes from the international transana... [more] Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Objective: This study aims to report short-term clinical and oncological outcomes from the international transanal Total Mesorectal Excision (taTME) registry for benign and malignant rectal pathology. Background: TaTME is the latest minimally invasive transanal technique pioneered to facilitate difficult pelvic dissections. Outcomes have been published from small cohorts, but larger series can further assess the safety and efficacy of taTME in the wider surgical population. Methods: Data were analyzed from 66 registered units in 23 countries. The primary endpoint was "good-quality TME surgery." Secondary endpoints were short-term adverse events. Univariate and multivariate regression analyses were used to identify independent predictors of poor specimen outcome. Results: A total of 720 consecutively registered cases were analyzed comprising 634 patients with rectal cancer and 86 with benign pathology. Approximately, 67% were males with mean BMI 26.5 kg/m 2. Abdominal or perineal conversion was 6.3% and 2.8%, respectively. Intact TME specimens were achieved in 85%, with minor defects in 11% and major defects in 4%. R1 resection rate was 2.7%. Postoperative mortality and morbidity were 0.5% and 32.6% respectively. Risk factors for poor specimen outcome (suboptimal TME specimen, perforation, and/or R1 resection) on multivariate analysis were positive CRM on staging MRI, low rectal tumor < 2 cm from anorectal junction, and laparoscopic transabdominal posterior dissection to < 4 cm from anal verge. Conclusions: TaTME appears to be an oncologically safe and effective technique for distal mesorectal dissection with acceptable short-term patient outcomes and good specimen quality. Ongoing structured training and the upcoming randomized controlled trials are needed to assess the technique further.
|
||||||||||
| 2017 |
Smith SR, Pockney P, Holmes R, Doig F, Attia J, Holliday E, et al., 'Biomarkers and anastomotic leakage in colorectal surgery: C-reactive protein trajectory is the gold standard.', ANZ journal of surgery, (2017)
|
||||||||||
| 2017 |
Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, et al., 'Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing', MOLECULAR ONCOLOGY, 11 208-219 (2017) [C1]
|
||||||||||
| 2015 |
Smith S, Pockney P, Attia J, 'Corrigendum: A Meta-analysis on the Effect of Sham Feeding Following Colectomy: Should Gum Chewing Be Included in Enhanced Recovery After Surgery Protocols?', Diseases of the colon and rectum, 58 e416 (2015) [O1]
|
||||||||||
| 2015 |
Smith SR, Draganic B, Pockney P, Holz P, Holmes R, Mcmanus B, Carroll R, 'Transversus abdominis plane blockade in laparoscopic colorectal surgery: a double-blind randomized clinical trial', INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 30 1237-1245 (2015) [C1]
|
||||||||||
| 2014 |
Ho YM, Smith SR, Pockney P, Lim P, Attia J, 'A Meta-analysis on the Effect of Sham Feeding Following Colectomy: Should Gum Chewing Be Included in Enhanced Recovery After Surgery Protocols?', DISEASES OF THE COLON & RECTUM, 57 115-126 (2014) [C1]
|
||||||||||
| 2010 |
Reid K, Pockney P, Draganic B, Smith S, 'Barrier wound protection decreases surgical site infection in open elective colorectal surgery: A randomized clinical trial', Diseases of the Colon & Rectum, 53 1374-1380 (2010) [C1]
|
||||||||||
| Show 20 more journal articles | |||||||||||
Conference (3 outputs)
| Year | Citation | Altmetrics | Link | |||||
|---|---|---|---|---|---|---|---|---|
| 2015 |
Scott R, Dooley S, Lewis W, Meldrum C, Pockney P, Draganic B, et al., 'Concordance of RAS mutation status in CRC patients by comparison of results from circulating tumour DNA and tissue-based testing', ANNALS OF ONCOLOGY, Barcelona, SPAIN (2015) [E3]
|
|||||||
| 2013 |
Grice DM, Bauer DC, Duesing K, Li D, Greenfield P, Nielsen S, et al., 'Human and microbial transcriptomics from lean and obese individuals with colorectal cancer: A comparison of Total and Poly A RNA sequencing from clinical samples.', CANCER RESEARCH, Washington, DC (2013) [E3]
|
|||||||
| 2003 |
King AT, Pockney PG, Clancy MJ, Moore BA, Bailey IS, 'An Early Warning System reliably identifies high-risk surgical ward patients early in their clinical deterioration', BRITISH JOURNAL OF ANAESTHESIA, LONDON, ENGLAND (2003)
|
|||||||
Grants and Funding
Summary
| Number of grants | 21 |
|---|---|
| Total funding | $1,133,798 |
Click on a grant title below to expand the full details for that specific grant.
201811 grants / $650,722
HMRI MRSP Infrastructure Funding Cancer Program 2018$183,208
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Doctor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | G1800336 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
The role of microbial oxygen sensing in the development of anastomotic leaks$97,220
Funding body: Fisher & Paykel Healthcare Limited
| Funding body | Fisher & Paykel Healthcare Limited |
|---|---|
| Project Team | Associate Professor Simon Keely, Doctor Peter Pockney, Doctor Steve Smith |
| Scheme | Research Consultancy |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2019 |
| GNo | G1701624 |
| Type Of Funding | C3211 - International For profit |
| Category | 3211 |
| UON | Y |
Mary Sawyer Postgraduate Scholarship in Cancer Research$85,500
Funding body: Hunter Medical Research Institute
| Funding body | Hunter Medical Research Institute |
|---|---|
| Project Team | Dr Georgia Carroll, Associate Professor Simon Keely, Doctor Peter Pockney, Professor Marjorie Walker, Doctor Steve Smith, Doctor Andrea Mathe |
| Scheme | Postgraduate Research Scholarship |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2020 |
| GNo | G1800612 |
| Type Of Funding | C3120 - Aust Philanthropy |
| Category | 3120 |
| UON | Y |
Investigation of disease markers in asymptomatic patients with colorectal carcinoma or colonic adenomas$81,337
Funding body: Streck
| Funding body | Streck |
|---|---|
| Project Team | Doctor Matt Dun, Doctor Peter Pockney |
| Scheme | Research Grant |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2019 |
| GNo | G1800707 |
| Type Of Funding | C3211 - International For profit |
| Category | 3211 |
| UON | Y |
Subproject: HMRI MRSP Infrastructure Funding Cancer Program 2018$65,756
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Doctor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | GS180006 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
Subproject: HMRI MRSP Infrastructure Funding Cancer Program 2018$52,000
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Doctor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | GS180007 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
Subproject: HMRI MRSP Infrastructure Funding Cancer Program 2018$21,009
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Doctor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | GS180008 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
Analysis of luminal bacteria at the site of colorectal anastomoses and their association with anastomotic leaks$20,000
Funding body: Hunter Medical Research Institute
| Funding body | Hunter Medical Research Institute |
|---|---|
| Project Team | Associate Professor Simon Keely, Doctor Peter Pockney, Doctor Steve Smith, Associate Professor Ian Grainge, Doctor Andrea Mathe |
| Scheme | Project Grant |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | G1701630 |
| Type Of Funding | C3120 - Aust Philanthropy |
| Category | 3120 |
| UON | Y |
A novel minimally invasive assay to identify patients with bowel cancer$20,000
Funding body: Rotary
| Funding body | Rotary |
|---|---|
| Project Team | Doctor Peter Pockney, Laureate Professor Rodney Scott |
| Scheme | Research Funding |
| Role | Lead |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | G1800199 |
| Type Of Funding | C3120 - Aust Philanthropy |
| Category | 3120 |
| UON | Y |
Subproject: HMRI MRSP Infrastructure Funding Cancer Program 2018$14,692
Funding body: NSW Ministry of Health
| Funding body | NSW Ministry of Health |
|---|---|
| Project Team | Conjoint Professor Stephen Ackland, Professor Xu Dong Zhang, Laureate Professor Rodney Scott, Doctor Nikki Verrills, Doctor Peter Pockney, Doctor James Lynam, Professor Christine Paul, Professor Amanda Baker |
| Scheme | Medical Research Support Program (MRSP) |
| Role | Investigator |
| Funding Start | 2018 |
| Funding Finish | 2018 |
| GNo | GS180004 |
| Type Of Funding | C2220 - Aust StateTerritoryLocal - Other |
| Category | 2220 |
| UON | Y |
Micro Leaks$10,000
Funding body: Hunter New England Local Health District
| Funding body | Hunter New England Local Health District |
|---|---|
| Project Team | Doctor Peter Pockney |
| Scheme | Project Grant |
| Role | Lead |
| Funding Start | 2018 |
| Funding Finish | 2020 |
| GNo | G1800374 |
| Type Of Funding | C2210 - Aust StateTerritoryLocal - Own Purpose |
| Category | 2210 |
| UON | Y |
20173 grants / $201,000
Improving access to colonoscopy by targeted waitlist management$141,000
Funding body: Cancer Institute of NSW
| Funding body | Cancer Institute of NSW |
|---|---|
| Project Team | C/Professor Jon Gani, C A/Prof Tony Proietto, Dr R Foster, Ms D Gillies, Mrs J Lack |
| Scheme | Innovations in Cancer Control Grants |
| Role | Lead |
| Funding Start | 2017 |
| Funding Finish | 2018 |
| GNo | |
| Type Of Funding | Grant - Aust Non Government |
| Category | 3AFG |
| UON | N |
HCRA Infrastructure Funding$40,000
Funding body: Hunter Cancer Research Alliance (HCRA)
| Funding body | Hunter Cancer Research Alliance (HCRA) |
|---|---|
| Scheme | .... |
| Role | Lead |
| Funding Start | 2017 |
| Funding Finish | 2017 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
The Impact of Surgery, Inflammation and Sepsis on Neutrophil Extracellular Trap (NET) Formation and Subsequent Metastatic Disease in Colorectal Cancer$20,000
Funding body: John Hunter Charitable Trust Grant
| Funding body | John Hunter Charitable Trust Grant |
|---|---|
| Scheme | John Hunter Charitable Trust Grant |
| Role | Lead |
| Funding Start | 2017 |
| Funding Finish | 2017 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20162 grants / $111,200
Improving Access to Colonoscopy for Diagnosis of Symptomatic Patients at High Risk of Colorectal Cancer (CRD) in HNE LHD$90,000
Funding body: Cancer Instititue NSW
| Funding body | Cancer Instititue NSW |
|---|---|
| Scheme | Innovation Grant |
| Role | Lead |
| Funding Start | 2016 |
| Funding Finish | 2016 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
A Propective Observational Study of CRP Velocity in Suspected Acute Appendicitis$21,200
Funding body: John Hunter Charitable Trust Grant
| Funding body | John Hunter Charitable Trust Grant |
|---|---|
| Scheme | John Hunter Charitable Trust Grant |
| Role | Lead |
| Funding Start | 2016 |
| Funding Finish | 2016 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20133 grants / $120,876
Introduction of Streamlined Access Pathways for Potential Colorectal Cancer Cases in the Lower Hunter$50,000
Funding body: Cancer Institute NSW
| Funding body | Cancer Institute NSW |
|---|---|
| Scheme | Evidence to Practice Grant |
| Role | Lead |
| Funding Start | 2013 |
| Funding Finish | 2013 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
Providing tailored web-based information to support colorectal cancer patients in their preparation for and recovery from surgery: A feasibility study$48,656
Funding body: Cancer Institute NSW
| Funding body | Cancer Institute NSW |
|---|---|
| Project Team | Laureate Professor Robert Sanson-Fisher, Doctor Steve Smith, Doctor Sancha Robinson, Ms Gill Batt, Conjoint Associate Professor Frans Henskens, Conjoint Associate Professor Ross Kerridge, Doctor Christopher Oldmeadow, Doctor Peter Pockney, Doctor Christopher Hayes |
| Scheme | Evidence to Practice Grant |
| Role | Investigator |
| Funding Start | 2013 |
| Funding Finish | 2013 |
| GNo | G1300868 |
| Type Of Funding | Other Public Sector - State |
| Category | 2OPS |
| UON | Y |
A Phase 3 Randomised, Double Blind, Placebo Controlled Pragmatic Trial to Assess the Efficacy of Tranexamic Acid in Reducing the Blood Loss in Patients with Per Rectal Bleeding$22,220
Funding body: John Hunter Charitable Trust Grant
| Funding body | John Hunter Charitable Trust Grant |
|---|---|
| Scheme | John Hunter Charitable Trust Grant |
| Role | Lead |
| Funding Start | 2013 |
| Funding Finish | 2013 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20121 grants / $20,000
Standardisation of Operative Equipment and Techniques for Common Acute General Surgery Operations$20,000
Funding body: Hunter New England LHD, NSW Health
| Funding body | Hunter New England LHD, NSW Health |
|---|---|
| Scheme | Innovation Support Scholarship |
| Role | Lead |
| Funding Start | 2012 |
| Funding Finish | 2012 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
20111 grants / $30,000
Donation to Support CNC GI Clinical Research Position$30,000
Funding body: Hunter New England LHD, NSW Health
| Funding body | Hunter New England LHD, NSW Health |
|---|---|
| Scheme | Division of Surgery |
| Role | Lead |
| Funding Start | 2011 |
| Funding Finish | 2011 |
| GNo | |
| Type Of Funding | External |
| Category | EXTE |
| UON | N |
Research Supervision
Number of supervisions
Total current UON EFTSL
Current Supervision
| Commenced | Level of Study | Research Title | Program | Supervisor Type |
|---|---|---|---|---|
| 2018 | PhD | The Role of Microbial Oxygen Sensing in the Development of Anastomotic Leaks | PhD (Human Physiology), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2018 | PhD | The Functional Effects of CD36 Polymorphisms in Colorectal Cancer | PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2017 | PhD | Circulating Tumour DNA as a Novel Biomarker for Colorectal Cancer | PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2017 | PhD | The Impact of Surgery, Inflammation and Sepsis on Neutrophil Extracellular Trap (NET) Formation and Subsequent Metastatic Disease in Colorectal Cancer | PhD (Surgical Science), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
| 2017 | PhD | Nerve Dependence in Human Cancers | PhD (Medicine), Faculty of Health and Medicine, The University of Newcastle | Co-Supervisor |
Past Supervision
| Year | Level of Study | Research Title | Program | Supervisor Type |
|---|---|---|---|---|
| 2016 | Masters |
A Potential Modifier Gene in Familial Adenosis Polyposis This was a project that examined the genes of patients with FAP looking for evidence of modifier genes that affect the age of onset of polyposis and of developing cancer in patients with FAP. |
Genetics, University of Edinburgh | Co-Supervisor |
| 2014 | Masters |
Haemorhoid Goligher grade versus symptom severity This was a pilot study of the correlation of patient reported symptoms compared to surgeon assessed clinical severity. |
Surgery, The University of Sydney | Principal Supervisor |
| 2014 | Honours |
Development of a Novel CO2 Insulflation Device for Laparotomy This was an honours student project that developed a device that provided a constant infusion of CO2 to the wound edge in an animal model of a laparotomy wound, with the long term aim of developing a device that can reduce the incidence of aerobic infections in surgical wounds. |
Surgery, NEWCASTLE UNIVERSITY | Co-Supervisor |
| 2013 | Honours |
A randomised clinical trial to assess the efficacy of bolus vs infusion as a mode of delivery for local anaesthetic blocks following abdominal surgery This was a randomised clinical trial of two methods of delivery of local anaesthetic to manage post-operative pain in patients who underwent abdominal surgery. The trial showed a modest difference in favour of bolus delivery. The trial included 120 patients. It has been presented at the Royal Australasian College of Surgeons Annual Scientific Meeting in 2015 |
Surgery, NEWCASTLE UNIVERSITY | Co-Supervisor |
Dr Peter Pockney
Position
Senior Lecturer
School of Medicine and Public Health
Faculty of Health and Medicine
Focus area
Medicine
Contact Details
| peter.pockney@newcastle.edu.au | |
| Phone | (02) 4985 5527 |
| Fax | (02) 4921 4274 |
Office
| Building | . |
|---|---|
| Location | John Hunter Hospital, Newcastle , |
Connect with me
